
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Auteur Sandra FRIEDMAN
|
|
Documents disponibles écrits par cet auteur (3)
Faire une suggestion Affiner la rechercheAssociations of maternal peripregnancy cannabis use with behavioral and developmental outcomes in children with and without symptoms of autism spectrum disorder: Study to Explore Early Development / Carolyn G. DIGUISEPPI ; Tessa CRUME ; Brady HOLST ; Kaylynn AIONA ; Julia VAN DYKE ; Lisa A. CROEN ; Julie L. DANIELS ; Sandra FRIEDMAN ; Katherine R. SABOURIN ; Laura A. SCHIEVE ; Lisa WIGGINS ; Gayle C. WINDHAM ; Cordelia ROBINSON ROSENBERG in Autism Research, 18-1 (January 2025)
![]()
[article]
Titre : Associations of maternal peripregnancy cannabis use with behavioral and developmental outcomes in children with and without symptoms of autism spectrum disorder: Study to Explore Early Development : Autism Research Type de document : texte imprimé Auteurs : Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Brady HOLST, Auteur ; Kaylynn AIONA, Auteur ; Julia VAN DYKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Sandra FRIEDMAN, Auteur ; Katherine R. SABOURIN, Auteur ; Laura A. SCHIEVE, Auteur ; Lisa WIGGINS, Auteur ; Gayle C. WINDHAM, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur Article en page(s) : p.202-216 Langues : Anglais (eng) Mots-clés : autism spectrum disorder cannabis child behavior child preschool developmental disabilities pregnancy prenatal risk factors sleep wake disorders Index. décimale : PER Périodiques Résumé : Abstract Some studies report increased prevalence of autism spectrum disorder (ASD) and associated symptoms with prenatal cannabis exposure. We examined whether associations of maternal cannabis use from 3 months preconception through delivery (?peripregnancy?) with behavior and development in the offspring varied with the presence of ASD symptoms. Children ages 30 68 months with ASD symptoms (i.e., met study criteria for ASD or had ASD symptoms on standardized assessments or community ASD diagnosis, N 2734) and without ASD symptoms (other developmental delay/disorders or general population sample, N 3454) were evaluated with the Child Behavior Checklist and Mullen Scales of Early Learning. We examined cannabis use during three time periods: peripregnancy, pregnancy, and only preconception. Peripregnancy cannabis exposure was reported for 6.0% of children with and 4.6% of children without ASD symptoms. Preconception-only cannabis use (versus no use) was associated with more aggressive behavior, emotional reactivity, and sleep problems in children with ASD symptoms, but not in children without ASD symptoms. Cannabis use during pregnancy was associated with increased attention and sleep problems in children with ASD symptoms; these associations did not differ significantly by ASD symptoms. Peripregnancy cannabis use was not associated with child developmental abilities regardless of ASD symptoms. In summary, associations of peripregnancy cannabis use with some behavioral outcomes differed in children with and without ASD symptoms. With rising cannabis use among pregnant women, future studies that examine a range of developmental risks associated with timing and patterns of cannabis use prior to conception as well as during pregnancy could inform clinical guidance. En ligne : https://doi.org/10.1002/aur.3284 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=546
in Autism Research > 18-1 (January 2025) . - p.202-216[article] Associations of maternal peripregnancy cannabis use with behavioral and developmental outcomes in children with and without symptoms of autism spectrum disorder: Study to Explore Early Development : Autism Research [texte imprimé] / Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Brady HOLST, Auteur ; Kaylynn AIONA, Auteur ; Julia VAN DYKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Sandra FRIEDMAN, Auteur ; Katherine R. SABOURIN, Auteur ; Laura A. SCHIEVE, Auteur ; Lisa WIGGINS, Auteur ; Gayle C. WINDHAM, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur . - p.202-216.
Langues : Anglais (eng)
in Autism Research > 18-1 (January 2025) . - p.202-216
Mots-clés : autism spectrum disorder cannabis child behavior child preschool developmental disabilities pregnancy prenatal risk factors sleep wake disorders Index. décimale : PER Périodiques Résumé : Abstract Some studies report increased prevalence of autism spectrum disorder (ASD) and associated symptoms with prenatal cannabis exposure. We examined whether associations of maternal cannabis use from 3 months preconception through delivery (?peripregnancy?) with behavior and development in the offspring varied with the presence of ASD symptoms. Children ages 30 68 months with ASD symptoms (i.e., met study criteria for ASD or had ASD symptoms on standardized assessments or community ASD diagnosis, N 2734) and without ASD symptoms (other developmental delay/disorders or general population sample, N 3454) were evaluated with the Child Behavior Checklist and Mullen Scales of Early Learning. We examined cannabis use during three time periods: peripregnancy, pregnancy, and only preconception. Peripregnancy cannabis exposure was reported for 6.0% of children with and 4.6% of children without ASD symptoms. Preconception-only cannabis use (versus no use) was associated with more aggressive behavior, emotional reactivity, and sleep problems in children with ASD symptoms, but not in children without ASD symptoms. Cannabis use during pregnancy was associated with increased attention and sleep problems in children with ASD symptoms; these associations did not differ significantly by ASD symptoms. Peripregnancy cannabis use was not associated with child developmental abilities regardless of ASD symptoms. In summary, associations of peripregnancy cannabis use with some behavioral outcomes differed in children with and without ASD symptoms. With rising cannabis use among pregnant women, future studies that examine a range of developmental risks associated with timing and patterns of cannabis use prior to conception as well as during pregnancy could inform clinical guidance. En ligne : https://doi.org/10.1002/aur.3284 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=546 Developmental Profiles of Young Children Referred for Concern for Autism Spectrum Disorder: DBPNet Study / Nancy ROIZEN in Journal of Autism and Developmental Disorders, 56-8 (August 2026)
![]()
[article]
Titre : Developmental Profiles of Young Children Referred for Concern for Autism Spectrum Disorder: DBPNet Study Type de document : texte imprimé Auteurs : Nancy ROIZEN, Auteur ; Sandra FRIEDMAN, Auteur ; Douglas VANDERBILT, Auteur ; Jaclyn CACIA, Auteur ; Jill FUSSELL, Auteur ; Robin HANSEN, Auteur ; Johannes HOFER, Auteur ; Georgio SIDERIDIS, Auteur ; Ruth E. K. STEIN, Auteur ; William BARBARESI, Auteur Article en page(s) : p.3288-3294 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : The aim of this study was to compare differences in cognitive, adaptive, and language function in young children referred for concerns for autism spectrum disorder (ASD) who are diagnosed with ASD vs those not diagnosed with ASD (no ASD). This prospective diagnostic study of 349 children < 6 years of age, with 250 diagnosed with ASD and 99 with no ASD, was conducted at 8 diagnostic centers. There were no differences in cognition between those diagnosed with ASD and those with no ASD. As compared to those with no ASD, children with ASD had significantly lower language and adaptive functioning. Children with no ASD had language and adaptive functioning similar to their cognitive function. Differences between developmental domains were also compared within the ASD and no ASD groups. There were no differences between any 2 areas of function in the no ASD group. However, there were significant differences within the ASD group, with cognitive function significantly higher than both language function and adaptive function. This study suggests that a discrepancy between adaptive and language skills beyond that expected based on cognitive function should heighten concern for ASD. Beyond the categorical diagnosis of ASD, it is important to assess all these developmental domains to develop comprehensive plans for interventions. En ligne : https://doi.org/10.1007/s10803-025-06777-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=591
in Journal of Autism and Developmental Disorders > 56-8 (August 2026) . - p.3288-3294[article] Developmental Profiles of Young Children Referred for Concern for Autism Spectrum Disorder: DBPNet Study [texte imprimé] / Nancy ROIZEN, Auteur ; Sandra FRIEDMAN, Auteur ; Douglas VANDERBILT, Auteur ; Jaclyn CACIA, Auteur ; Jill FUSSELL, Auteur ; Robin HANSEN, Auteur ; Johannes HOFER, Auteur ; Georgio SIDERIDIS, Auteur ; Ruth E. K. STEIN, Auteur ; William BARBARESI, Auteur . - p.3288-3294.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 56-8 (August 2026) . - p.3288-3294
Index. décimale : PER Périodiques Résumé : The aim of this study was to compare differences in cognitive, adaptive, and language function in young children referred for concerns for autism spectrum disorder (ASD) who are diagnosed with ASD vs those not diagnosed with ASD (no ASD). This prospective diagnostic study of 349 children < 6 years of age, with 250 diagnosed with ASD and 99 with no ASD, was conducted at 8 diagnostic centers. There were no differences in cognition between those diagnosed with ASD and those with no ASD. As compared to those with no ASD, children with ASD had significantly lower language and adaptive functioning. Children with no ASD had language and adaptive functioning similar to their cognitive function. Differences between developmental domains were also compared within the ASD and no ASD groups. There were no differences between any 2 areas of function in the no ASD group. However, there were significant differences within the ASD group, with cognitive function significantly higher than both language function and adaptive function. This study suggests that a discrepancy between adaptive and language skills beyond that expected based on cognitive function should heighten concern for ASD. Beyond the categorical diagnosis of ASD, it is important to assess all these developmental domains to develop comprehensive plans for interventions. En ligne : https://doi.org/10.1007/s10803-025-06777-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=591 Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development / Carolyn G. DIGUISEPPI in Journal of Autism and Developmental Disorders, 52-11 (November 2022)
![]()
[article]
Titre : Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development Type de document : texte imprimé Auteurs : Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur Article en page(s) : p.5064-5071 Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3 months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68 months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071[article] Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development [texte imprimé] / Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur . - p.5064-5071.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071
Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3 months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68 months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489

